Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Duediligence33on Apr 16, 2017 5:03pm
353 Views
Post# 26125820

At THIS point in time vs future value

At THIS point in time vs future valueOn an annual basis roughly speaking Aphria has 20 million revenue and 8 million earnings with 55 sq ft capacity selling 2800 kg of Weed with a market capitalization of 1 Billion. Compared to Canopy way overvalued Share price will go down to $ 6.00 considering the future expansion Phase 2 yet to be approved by HC then 100,000 sq ft for summer harvest Phase 3 yet to be completed then approved then harvest by next year 2018 300,000 total Next phase 4 ready for 2019 by 2020 the share price will be over $ 20 but now the market will correct by summer and Canopy to $ 8.50. Both are good companies but both got hyped up over the real present valuations. I WILL buy both at those levels you will see by July then slow move to next year legalization NOW the reality of provincial deliberations for distribution will occupy the discussions
Bullboard Posts